Tumor suppressive activity of anti-CD274 antibody as an immune checkpoint inhibitor for cervical cancer mouse model

被引:0
|
作者
Murakami, Kazuyuki [1 ]
Yoshino, Naoto [2 ]
Kawamura, Hanae [1 ]
Sasaki, Yutaka [2 ]
Kagabu, Masahiro [1 ]
Muraki, Yasushi [2 ]
Sugiyama, Toru [1 ]
机构
[1] Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, Morioka, Iwate, Japan
[2] Iwate Med Univ, Sch Med, Div Infect Dis & Immunol, Dept Microbiol, Morioka, Iwate, Japan
关键词
D O I
10.1016/j.jri.2015.09.059
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
56
引用
收藏
页码:139 / 139
页数:1
相关论文
共 50 条
  • [41] Immune cell phenotype and cytokine secretion in mouse breast cancer responding to anti-CD47 antibody treatment
    Wen, Chiao Kai
    Elia, Jeanne
    Loter, Lorraine
    Rafizadeh, Tannaz
    Jiang, Weiping
    Zhang, Hong
    Yang, Xifeng
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [42] Immune cell phenotype and cytokine secretion in mouse breast cancer responding to anti-CD47 antibody treatment
    Wen, C.
    Elia, J.
    Jiang, W.
    Zhang, H.
    Yang, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1774 - 1774
  • [43] A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
    Gonda, Tamas A.
    Fang, Jarwei
    Salas, Martha
    Do, Catherine
    Hsu, Emily
    Zhukovskaya, Anna
    Siegel, Ariel
    Takahashi, Ryota
    Lopez-Bujanda, Zoila A.
    Drake, Charles G.
    Manji, Gulam A.
    Wang, Timothy C.
    Olive, Kenneth P.
    Tycko, Benjamin
    CANCER RESEARCH, 2020, 80 (21) : 4754 - 4767
  • [44] A bispecific antibody targeting IGF-IR and EGFR has tumor and metastasis suppressive activity in an orthotopic xenograft osteosarcoma mouse model
    Gvozdenovic, Ana
    Boro, Aleksandar
    Born, Walter
    Muff, Roman
    Fuchs, Bruno
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (07): : 1435 - 1449
  • [45] Combination of anti-PD-1 antibody and PDGFR inhibitor inhibits metastasis of colorectal cancer in a mouse model
    Kadota, Hiroki
    Yuge, Ryo
    Ariyoshi, Misa
    Shimizu, Daisuke
    Miyamoto, Ryo
    Ohtani, Rina
    Takigawa, Hidehiko
    Oka, Shiro
    Kitadai, Yasuhiko
    Tanaka, Shinji
    CANCER SCIENCE, 2023, 114 : 1403 - 1403
  • [46] AGING IS ASSOCIATED WITH AN ANTI-TUMOR IMMUNE MICROENVIRONMENT IN A GENETICALLY ENGINEERED MOUSE MODEL OF COLORECTAL CANCER
    Mirminachi, Babak
    Liu, Yang
    Wade, Paul
    Roper, Jatin
    GASTROENTEROLOGY, 2023, 164 (06) : S24 - S24
  • [47] Biomarkers of immune checkpoint inhibitor response in metastatic breast cancer: PD-L1 protein expression, CD274 gene amplification, and total mutational burden
    Ross, Jeffrey S.
    Gay, Laurie M.
    Sheehan, Christine E.
    Dalvi, Siddhartha
    Voronel, Olga
    Elvin, Julia Andrea
    Suh, James
    Vergilio, Jo-Anne
    Frampton, Garrett Michael
    Fabrizio, David
    Chalmers, Zachary Rockow
    Chumsri, Saranya
    Ali, Siraj Mahamed
    Miller, Vincent A.
    Stephens, Philip J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Synergistic anti-tumor efficacy of a hollow mesoporous silica-based cancer vaccine and an immune checkpoint inhibitor at the local site
    Wang, Xiupeng
    Li, Xia
    Ito, Atsuo
    Sogo, Yu
    Ohno, Tadao
    ACTA BIOMATERIALIA, 2022, 145 : 235 - 245
  • [49] Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer
    Bommireddy, Ramireddy
    Munoz, Luis E.
    Kumari, Anita
    Huang, Lei
    Fan, Yijian
    Monterroza, Lenore
    Pack, Christopher D.
    Ramachandiran, Sampath
    Reddy, Shaker J. C.
    Kim, Janet
    Chen, Zhuo G.
    Saba, Nabil F.
    Shin, Dong M.
    Selvaraj, Periasamy
    VACCINES, 2020, 8 (02)
  • [50] Safety and efficacy of murine PVSRIPO plus anti-PD1 immune checkpoint inhibitor (ICI) in a melanoma tumor model.
    Neighbours, Lauren
    McKay, Zachary P.
    Gromeier, Matthias
    Nichols, Garrett
    Kelly, Andrea True
    Corum, Daniel
    Brown, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)